Inmed Pharmaceuticals Stock Price History

INM Stock  USD 4.95  0.45  10.00%   
Below is the normalized historical share price chart for InMed Pharmaceuticals extending back to December 30, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of InMed Pharmaceuticals stands at 4.95, as last reported on the 18th of January 2025, with the highest price reaching 4.95 and the lowest price hitting 4.40 during the day.
IPO Date
12th of November 2020
200 Day MA
5.1682
50 Day MA
4.6738
Beta
0.711
 
Yuan Drop
 
Covid
If you're considering investing in InMed Stock, it is important to understand the factors that can impact its price. InMed Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0058, which attests that the entity had a -0.0058% return per unit of volatility over the last 3 months. InMed Pharmaceuticals exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out InMed Pharmaceuticals' risk adjusted performance of 0.0699, and Market Risk Adjusted Performance of (19.71) to validate the risk estimate we provide.
  
At this time, InMed Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 18th of January 2025, Common Stock Shares Outstanding is likely to grow to about 9.2 M, while Common Stock is likely to drop about 53.5 M. . As of the 18th of January 2025, Price To Sales Ratio is likely to drop to 0.81. In addition to that, Price Earnings Ratio is likely to drop to -1.24. InMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0058

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsINM

Estimated Market Risk

 6.61
  actual daily
58
58% of assets are less volatile

Expected Return

 -0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average InMed Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of InMed Pharmaceuticals by adding InMed Pharmaceuticals to a well-diversified portfolio.
Price Book
0.427
Enterprise Value Ebitda
0.9967
Price Sales
0.7796
Shares Float
13.3 M
Wall Street Target Price
20

InMed Pharmaceuticals Stock Price History Chart

There are several ways to analyze InMed Stock price data. The simplest method is using a basic InMed candlestick price chart, which shows InMed Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 28, 20247.1
Lowest PriceJanuary 14, 20254.08

InMed Pharmaceuticals January 18, 2025 Stock Price Synopsis

Various analyses of InMed Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell InMed Stock. It can be used to describe the percentage change in the price of InMed Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of InMed Stock.
InMed Pharmaceuticals Price Daily Balance Of Power 0.82 
InMed Pharmaceuticals Price Action Indicator 0.50 
InMed Pharmaceuticals Price Rate Of Daily Change 1.10 

InMed Pharmaceuticals January 18, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in InMed Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use InMed Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in InMed Stock and then apply it to test your longer-term investment strategies against InMed.

InMed Stock Price History Data

The price series of InMed Pharmaceuticals for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 3.02 with a coefficient of variation of 12.59. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.87. The median price for the last 90 days is 4.72. The company completed 1:20 stock split on 14th of November 2024. InMed Pharmaceuticals completed dividends distribution on 2020-07-06.
OpenHighLowCloseVolume
01/18/2025
 4.43  4.95  4.40  4.95 
01/17/2025 4.43  4.95  4.40  4.95  39,842 
01/16/2025 4.58  4.60  4.07  4.50  21,018 
01/15/2025 4.12  4.38  4.10  4.34  12,307 
01/14/2025 4.21  4.36  3.98  4.08  28,336 
01/13/2025 4.30  4.30  4.20  4.22  9,047 
01/10/2025 4.59  4.73  4.26  4.31  52,837 
01/08/2025 4.79  4.88  4.11  4.51  94,477 
01/07/2025 4.97  5.08  4.77  4.79  20,203 
01/06/2025 5.00  5.41  4.95  4.97  49,097 
01/03/2025 4.77  4.99  4.76  4.97  15,523 
01/02/2025 4.68  4.80  4.40  4.80  13,380 
12/31/2024 4.50  4.79  4.32  4.74  25,991 
12/30/2024 4.74  4.74  4.46  4.59  9,505 
12/27/2024 4.68  4.74  4.50  4.74  8,580 
12/26/2024 4.66  4.73  4.57  4.59  8,680 
12/24/2024 4.54  4.68  4.54  4.66  9,288 
12/23/2024 4.40  4.80  4.40  4.68  17,416 
12/20/2024 4.20  4.51  4.14  4.40  40,446 
12/19/2024 4.47  4.69  4.14  4.14  23,410 
12/18/2024 5.15  5.15  4.35  4.35  32,167 
12/17/2024 5.19  5.27  5.09  5.19  4,605 
12/16/2024 5.11  5.23  5.11  5.19  4,641 
12/13/2024 5.15  5.26  5.06  5.26  7,115 
12/12/2024 5.22  5.22  5.06  5.15  10,388 
12/11/2024 5.29  5.29  5.06  5.19  11,947 
12/10/2024 5.11  5.30  5.09  5.11  13,193 
12/09/2024 5.51  5.54  5.04  5.08  20,369 
12/06/2024 5.58  6.40  5.19  5.50  134,510 
12/05/2024 4.50  5.50  4.46  5.42  111,543 
12/04/2024 4.42  4.64  4.33  4.51  16,844 
12/03/2024 4.33  4.47  4.20  4.42  24,866 
12/02/2024 4.30  4.45  4.22  4.33  18,984 
11/29/2024 4.30  4.48  4.29  4.29  14,145 
11/27/2024 4.52  4.75  4.20  4.30  19,621 
11/26/2024 4.51  4.90  4.36  4.53  21,748 
11/25/2024 4.62  4.98  4.33  4.50  25,972 
11/22/2024 4.67  4.97  4.59  4.66  32,751 
11/21/2024 4.19  4.97  4.11  4.65  51,314 
11/20/2024 4.11  4.33  4.09  4.23  20,648 
11/19/2024 4.34  4.56  4.02  4.35  82,571 
11/18/2024 4.28  4.29  3.65  4.24  29,443 
11/15/2024 5.08  5.13  4.28  4.28  92,254 
11/14/2024 4.67  5.41  4.14  5.08  201,484 
11/13/2024 5.02  5.20  4.65  4.65  851,432 
11/12/2024 5.00  5.34  4.76  5.04  38,530 
11/11/2024 4.85  5.00  4.61  4.88  37,008 
11/08/2024 4.60  4.84  4.52  4.72  17,840 
11/07/2024 4.40  4.74  4.30  4.70  13,050 
11/06/2024 4.50  4.78  4.30  4.52  18,495 
11/05/2024 4.70  4.82  4.40  4.50  28,925 
11/04/2024 5.28  5.48  4.70  4.86  16,450 
11/01/2024 5.27  5.46  5.21  5.21  183,444 
10/31/2024 5.84  5.86  5.20  5.32  23,560 
10/30/2024 5.72  6.00  5.56  5.86  23,925 
10/29/2024 6.20  6.38  5.60  5.80  57,355 
10/28/2024 6.88  7.16  6.42  7.10  195,800 
10/25/2024 5.66  7.16  5.66  6.66  81,700 
10/24/2024 5.80  6.00  5.50  5.80  22,980 
10/23/2024 6.40  6.40  5.60  5.94  42,825 
10/22/2024 6.04  6.58  5.48  6.38  145,750 

About InMed Pharmaceuticals Stock history

InMed Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for InMed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in InMed Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing InMed Pharmaceuticals stock prices may prove useful in developing a viable investing in InMed Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding8.7 M9.2 M
Net Loss-7.2 M-7.5 M

InMed Pharmaceuticals Quarterly Net Working Capital

6.72 Million

InMed Pharmaceuticals Stock Technical Analysis

InMed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of InMed Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of InMed Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

InMed Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for InMed Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of InMed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of InMed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether InMed Pharmaceuticals is a strong investment it is important to analyze InMed Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact InMed Pharmaceuticals' future performance. For an informed investment choice regarding InMed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InMed Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
253.44
Revenue Per Share
0.603
Quarterly Revenue Growth
(0.45)
Return On Assets
(0.39)
Return On Equity
(0.72)
The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if InMed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.